AI
HHS icon

Analytic Investors’s Harte-Hanks HHS Stock Holding History

Analytic Investors’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,911
Closed -$149K – 571
2013
Q4 		$149K Sell
1,911
-3,420
-64% -$279K ﹤0.01% 480
2013
Q3 		$471K Buy
+5,331
New +$488K 0.01% 393

Other funds holding HHS

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Analytic Investors's HHS Position: Q1 2014 in Review

Analytic Investors sold out of Harte-Hanks (HHS) in Q1 2014, closing a stake of 1,911 shares — an estimated $149K sold.

Analytic Investors first reported a position in HHS in Q3 2013 and held it in 2 quarters. The position peaked at $471K in Q3 2013. 122 funds tracked by Wall St. Rank hold HHS as of Q1 2014.

  • Analytic Investors reported no remaining Harte-Hanks position as of Q1 2014 after selling out during the quarter.
  • Analytic Investors sold 1,911 Harte-Hanks shares in Q1 2014, an estimated $149K.
  • Analytic Investors first reported a position in Harte-Hanks in Q3 2013 and held it in 2 quarters.
  • Analytic Investors's Harte-Hanks position peaked at $471K in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2014.

Based on Analytic Investors's 13F filing for Q1 2014, filed 12 May 2014.